Myriad Genetics Inc (MYGN)

May 25, 2026

MYGN Technical Analysis & Stock Price Forecast - Intellectia AI

May 25, 2026

May 23, 2026

Myriad Genetics (MYGN) price target decreased by 11.49% to 6.35 - MSN

May 23, 2026

May 23, 2026

Myriad Genetics | 5/22/26 - ktnv.com

May 23, 2026

May 22, 2026

MindWalk Holdings Leads Our Trio Of Promising Penny Stocks - simplywall.st

May 22, 2026

May 19, 2026

Myriad Genetics executives to speak at SOPHiA GENETICS event, spotlighting industry partnerships - Traders Union

May 19, 2026

May 18, 2026

‘American Idol’ Star Speaks Out on Health Issues 17 Years After Show Appearance - Parade

May 18, 2026

May 18, 2026

Down 29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Myriad (MYGN) - Yahoo Finance

May 18, 2026

May 17, 2026

Myriad Genetics in record sell-off after Q1 miss - MSN

May 17, 2026

May 16, 2026

Stocks With 20% Upside: Dollar Tree, Myriad Genetics, Antero Resources AnalysisNews and Statistics - IndexBox

May 16, 2026

May 16, 2026

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Rating of "Hold" by Analysts - MarketBeat

May 16, 2026

May 16, 2026

Myriad Genetics, Inc. $MYGN Shares Acquired by Vanguard Group Inc. - MarketBeat

May 16, 2026

May 15, 2026

Jackie Tohn joins Myriad Genetics in campaign to expand hereditary cancer test awareness - Traders Union

May 15, 2026

May 15, 2026

Myriad Genetics, Inc.Common Stock (NQ: MYGN - FinancialContent

May 15, 2026

May 15, 2026

Myriad Genetics and actress Jackie Tohn promote hereditary cancer testing after her BRCA1 gene discovery. - Pluang

May 15, 2026

May 15, 2026

Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life - markets.businessinsider.com

May 15, 2026

May 15, 2026

Myriad Genetics Partners with Jackie Tohn to Promote Hereditary Cancer Testing Awareness - Quiver Quantitative

May 15, 2026

May 15, 2026

Insider Buying: Paul Bisaro Acquires Shares of Myriad Genetics I - GuruFocus

May 15, 2026

May 14, 2026

Myriad Genetics’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

May 14, 2026

May 14, 2026

Myriad Genetics director Paul Bisaro buys $27,637 in stock By Investing.com - Investing.com Australia

May 14, 2026

May 14, 2026

Myriad Genetics director Paul Bisaro buys $27,637 in stock - Investing.com UK

May 14, 2026

May 14, 2026

Paul Bisaro (NASDAQ: MYGN) adds 7,500 Myriad Genetics shares - Stock Titan

May 14, 2026

May 14, 2026

Myriad Genetics Inc stock (US62855J1043): shares react to Q1 2025 results and updated 2025 guidance - AD HOC NEWS

May 14, 2026

May 14, 2026

Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight - GlobeNewswire Inc.

May 14, 2026

May 14, 2026

Myriad Genetics expands access to MyChoice Test for prostate cancer patients in Japan - SelectScience

May 14, 2026

May 14, 2026

Myriad Genetics unveils ultra-sensitive MRD testing focus at Tokyo oncology summit - Traders Union

May 14, 2026

May 12, 2026

Myriad Genetics stock (US62855J1043): Q1 2026 earnings miss and recent price drop - AD HOC NEWS

May 12, 2026

May 12, 2026

State Street (MYGN) reports 4.42M Myriad shares, 4.7% stake - Stock Titan

May 12, 2026

May 12, 2026

FirstGene Multiple Prenatal Screen launch drives engagement at ACOG2026, Myriad Genetics advances genetic care - Traders Union

May 12, 2026

May 11, 2026

Myriad Genetics Inc. (MYGN): Larry Robbins Likes This Stock - Insider Monkey

May 11, 2026

May 08, 2026

Myriad Genetics, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:MYGN) 2026-05-08 - Seeking Alpha

May 08, 2026

May 08, 2026

Myriad Genetics, Inc. (MYGN) Stock Analysis: Evaluating a Promising 77.94% Upside Potential - DirectorsTalk Interviews

May 08, 2026

May 07, 2026

Hereditary Cancer Testing Market Will Generate Booming Growth - openPR.com

May 07, 2026

May 07, 2026

Myriad Genetics Is Maintained at Equal-Weight by Wells Fargo - Moomoo

May 07, 2026

May 07, 2026

Myriad Genetics Is Maintained at Hold by TD Cowen - Moomoo

May 07, 2026

May 07, 2026

Myriad Genetics to join two healthcare conferences in upcoming weeks - Traders Union

May 07, 2026

May 07, 2026

Myriad Genetics to join BofA meetings, Goldman webcast in June - Stock Titan

May 07, 2026

May 07, 2026

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - GlobeNewswire

May 07, 2026

May 07, 2026

Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2026 Earnings Call Transcript - Insider Monkey

May 07, 2026

May 07, 2026

Myriad Genetics Bets on Growth Amid Profit Squeeze - TipRanks

May 07, 2026

May 07, 2026

Myriad Genetics (MYGN) Q1 Loss Of US$34.1 Million Reinforces Bearish Profitability Concerns - Sahm

May 07, 2026

May 06, 2026

Myriad Genetics (MYGN) reports Q1 loss, misses revenue estimates - MSN

May 06, 2026

May 06, 2026

Myriad Genetics Q1 2026 earnings preview - MSN

May 06, 2026

May 06, 2026

Myriad Genetics Q1 2026 Financial Results: Revenue Breakdown, Net Loss, and Key Financial Statements - Minichart

May 06, 2026